Advertisement

Plasma levels of granzyme B are increased in patients with lipid-rich carotid plaques as determined by echogenicity

      Abstract

      Increased echolucency of carotid plaques is associated with an increased risk of ischemic stroke. Inflammation and apoptosis of vascular smooth muscle cells in the arterial wall are involved in the atherosclerotic process and destabilization of the plaque. Granzyme B (GrB) is a key mediator of T cell-mediated cytotoxicity, and we therefore hypothesized that this protease could distinguish echolucent from other plaques.
      Ultrasound-determined echolucency of atherosclerotic plaques was assessed prior to carotid endarterectomy/angioplasty in 57 consecutively recruited patients with high-grade internal carotid stenosis. Plasma levels of GrB were measured by enzyme immunoassay prior to surgery.
      Patients with carotid atherosclerosis had significantly higher plasma levels of GrB compared to healthy controls (n = 16) (p < 0.01), with particularly high levels in those with an echolucent lesion. While there were no differences in traditional cardiovascular risk factors or CRP between those with echolucent (n = 16) and those with echogenic/heterogeneous (n = 41) plaques, the echolucent group had markedly raised plasma levels of GrB (p < 0.01). Patients with high levels of circulating granzyme B also had more ischemic lesions on cerebral MRI prior to surgery. Raised plasma levels of GrB in echolucent carotid plaques with increased frequency of cerebrovascular events suggest that GrB may be a marker of plaque instability.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Atherosclerosis
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Mathiesen E.B.
        • Bonaa K.H.
        • Joakimsen O.
        Echolucent plaques are associated with high risk of ischemic cerebrovascular events in carotid stenosis: the Tromsø study.
        Circulation. 2001; 103: 2171-2175
        • Nordestgaard B.G.
        Echolucent rupture-prone plaques.
        Curr Opin Lipidol. 2003; 14: 505-512
        • European Carotid Plaque Study G
        Carotid artery plaque composition—relationship to clinical presentation and ultrasound B-mode imaging.
        Eur J Vasc Endovasc Surg. 1995; 10: 23-30
        • Yamagami H.
        • Kitagawa K.
        • Nagai Y.
        • et al.
        Higher levels of Interleukin-6 are associated with lower echogenicity of carotid artery plaques.
        Stroke. 2004; 35: 677-681
        • Gronholdt M.L.
        • Nordestgaard B.G.
        • Bentzon J.
        • et al.
        Macrophages are associated with lipid-rich carotid artery plaques, echolucency on B-mode imaging, and elevated plasma lipid levels.
        J Vasc Surg. 2002; 35: 137-145
        • Choy J.C.
        • Hung V.H.Y.
        • Hunter A.L.
        • et al.
        Granzyme B induces smooth muscle cell apoptosis in the absence of perforin: involvement of extracellular matrix degradation.
        Arterioscler Thromb Vasc Biol. 2004; 24: 2245-2250
        • Choy J.
        • McDonald P.
        • Suarez A.C.
        • et al.
        Granzyme B in atherosclerosis and transplant vascular disease: association with cell death and atherosclerotic disease severity.
        Modern Pathol. 2003; 16: 460-470
        • Tak P.P.
        • Spaeny-Dekking L.
        • Kraan M.C.
        • et al.
        The levels of soluble granzyme A and B are elevated in plasma and synovial fluid of patients with rheumatoid arthritis (RA).
        Clin Exp Immunol. 1999; 116: 366-370
        • Anderson G.B.
        • Ashforth R.
        • Steinke D.E.
        • Ferdinandy R.
        • Findlay J.M.
        CT Angiography for the detection and characterization of carotid artery bifurcation disease.
        Stroke. 2000; 31: 2168-2174
        • Grant E.G.
        • Benson C.B.
        • Moneta G.L.
        • et al.
        Carotid artery stenosis: gray-scale and doppler US diagnosis—Society of Radiologists in Ultrasound Consensus Conference.
        Radiology. 2003; 229: 340-346
        • Holven K.B.
        • Scholz H.
        • Halvorsen B.
        • et al.
        Hyperhomocysteinemic subjects have enhanced expression of lectin-like oxidized LDL receptor-1 in mononuclear cells.
        J Nutr. 2003; 133: 3588-3591
        • Coutts S.B.
        • Hill M.D.
        • Simon J.E.
        • et al.
        Silent ischemia in minor stroke and TIA patients identified on MR imaging.
        Neurology. 2005; 65: 513-517
        • Hansson G.K.
        Inflammation, atherosclerosis, and coronary artery disease.
        N Engl J Med. 2005; 352: 1685-1695
        • Tsimikas S.
        • Willerson J.T.
        • Ridker P.M.
        C-reactive protein and other emerging blood biomarkers to optimize risk stratification of vulnerable patients.
        J Am Coll Cardiol. 2006; 47: C19-C31
        • Ridker P.M.
        Clinical application of C-reactive protein for cardiovascular disease detection and prevention.
        Circulation. 2003; 107: 363-369
        • Everett B.M.
        • Kurth T.
        • Buring J.E.
        • Ridker P.M.
        The relative strength of C-reactive protein and lipid levels as determinants of ischemic stroke compared with coronary heart disease in women.
        J Am Coll Cardiol. 2006; 48: 2235-2242
      1. With Not0 AA-TBgMEEA, Endothelial dysfunction and systemic inflammation in persons with echolucent carotid plaques. Thromb Haemost 2006;96:53–9.

        • Ridker P.M.
        • Hennekens C.H.
        • Buring J.E.
        • Rifai N.
        C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women.
        N Engl J Med. 2000; 342: 836-843
        • Robertson
        T cells in atherogenesis: for better or for worse?.
        Arterioscler Thromb Vasc Biol. 2006; 26: 2421